STANREC 4743
STANREC 4743 guidance on biological warfare agent challenge levels
National defence authorities and NATO bodies deciding whether to draw on AEP-72 Volume IV for biological warfare agent challenge levels in protective equipment design, and the suppliers whose contracts end up naming it
STANREC 4743 is a NATO recommendation, not a binding agreement, naming AEP-72 Volume IV as the source of biological warfare agent challenge levels for NATO protective equipment design.
- Edition
- 1
- Published
- 2016-04-19
What it is
A recommendation, not an obligation
STANREC 4743 is a NATO Standardization Recommendation on biological warfare agent challenge levels. The distinction that matters most is in its name: unlike a STANAG, a STANREC does not commit a nation to ratify anything. NATO's own text is explicit that this STANREC "is a non-binding document employed on a voluntary basis and does not require commitment of the nations to implement the standards which are listed in it" - a voluntary basis, not a ratification obligation. Nothing in this document creates a duty for a supplier to sign up to directly.
What it recommends
The document's aim is "to list recommended practices regarding: Deposition and dosage levels of biological warfare agents to which protective equipment and procedures for NATO forces should be designed to allow unaffected operations." Its recommendation is a single document: AEP-72, Volume IV, Edition A. STANREC 4743 does not expand on what AEP-72 Volume IV requires; the point of this cover document is to name it, not to reproduce it.
The same clause draws a distinction worth keeping straight: the levels are "intended to provide design guidelines," and the document is explicit that they are not to be used for "risk assessment". They are an input to design, not a method for assessing risk.
A family of related CBRN standards
Alongside the recommendation, the cover names twenty other NATO standardization documents without saying any of them bind anything here. Three are the other volumes of the same AEP-72 series - STANREC 4726 (chemical, biological and TIC challenge levels, Vol. 1), STANREC 4741 (chemical agent challenge levels, Vol. 2) and STANREC 4742 (toxic industrial chemicals challenge levels, Vol. 3). The rest cover the wider CBRN protective-equipment family: protective clothing (AEP-38, via STANREC 4548), respirators (AEP-71, via STANREC 4725), protective masks (AEP-73, via STANREC 4727), collective protection (AEP-54, via STANREC 4634), and CBRN defence on operations (ATP-3.8.1, via STANAG 2521 and STANAG 2522). Our standards explorer lists the rest.
A new recommendation, not a replacement
STANREC 4743 supersedes nothing: "This STANREC does not supersede any document." It is a fresh recommendation, not a consolidation of an earlier agreement.
Where the actual requirements live
STANREC 4743 has no clauses of its own to audit against. It is supervised under CNAD's AC/225 NATO Army Armaments Group (NAAG) and the Joint CBRN Capability Development Group. The document is reviewed at least once every three years, with the result recorded in the NATO Standardization Document Database; that review is the only ongoing mechanism it names, and it checks the document's own currency, not a piece of equipment or an organisation. The biological warfare agent challenge levels themselves sit inside AEP-72, Volume IV, not here.
How we help
STANREC 4743 itself gives an organisation nothing to implement in software: it recommends which publication to design protective equipment and procedures against, and the challenge-level values sit inside AEP-72, Volume IV, not here.
What is left is the ordinary discipline of evidencing a design basis: recording that a protective-equipment programme designs to AEP-72 Volume IV, holding that decision as a controlled document with its rationale, and keeping the design records and reviews that show a supplier worked to the challenge levels a contract specified. ComplyTrain gives a place to hold that documentation, track who approved it, and keep it linked to the programme and contract it applies to.
ComplyTrain does not conduct or witness the biological-agent testing that establishes or verifies challenge-level performance - that work happens in specialist defence and CBRN test facilities, against whatever AEP-72 Volume IV specifies. Which challenge levels a given contract requires is set by the contract and the customer's quality clause, not by this page. Our standards explorer shows what sits alongside STANREC 4743 - if you're weighing up what a tender is actually asking for, we're glad to talk it through.
Standards it references
- STANREC 4726Background
- STANREC 4741Background
- STANREC 4742Background
- STANREC 4548Background
- AEP-38Background
- STANREC 4725Background
- AEP-71Background
- STANREC 4727Background
- AEP-73Background
- STANREC 4634Background
- AEP-54Background
- STANAG 4521Background
- AEP-07Background
- STANAG 4653Background
- AEP-58Background
- STANAG 2521Background
- ATP-3.8.1Background
- STANAG 2522Background
- STANAG 2103Background
- ATP-45Background
- STANAG 2553Background
Questions
Is STANREC 4743 mandatory?
No. A STANREC is a recommendation: NATO nations are not obliged to implement the standards it lists. Whether AEP-72 Volume IV applies to a specific programme is a question for that programme's contract.
What is the difference between a STANREC and a STANAG?
A STANAG is an agreement nations ratify and commit to implement. A STANREC recommends a standard without that obligation - it is voluntary, and nations decide for themselves whether to draw on it.
What does STANREC 4743 recommend?
It recommends a single document, AEP-72, Volume IV, Edition A, covering biological warfare agent challenge levels for the design of NATO protective equipment and procedures. STANREC 4743 does not itself set out those levels.
Are the challenge levels a risk assessment tool?
No. The document states directly that the levels are not to be used for "risk assessment". They are design guidelines for protective equipment and procedures, not a method for assessing risk.
Did STANREC 4743 replace an earlier document?
No. The document states plainly that it does not supersede any document. It is a new recommendation, not a consolidation of an earlier agreement.
